Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective

S Bindu, S Mazumder, U Bandyopadhyay - Biochemical pharmacology, 2020 - Elsevier
Owing to the efficacy in reducing pain and inflammation, non-steroidal anti-inflammatory
drugs (NSAIDs) are amongst the most popularly used medicines confirming their position in …

Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics

GS Chaudhry, A Md Akim, YY Sung… - Frontiers in …, 2022 - frontiersin.org
Cancer is a multifactorial, multi-stage disease, including complex cascades of signaling
pathways—the cell growth governed by dysregulated and abrupt cell division. Due to the …

Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF …

YJ Surh, KS Chun, HH Cha, SS Han, YS Keum… - Mutation Research …, 2001 - Elsevier
A wide array of phenolic substances, particularly those present in edible and medicinal
plants, have been reported to possess substantial anticarcinogenic and antimutagenic …

Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.

JG Einspahr, DS Alberts, SM Gapstur, RM Bostick… - … , biomarkers & prevention …, 1997 - AACR
Surrogate end-point biomarkers (SEBs) have become widely used in short-term cancer
chemoprevention trials in place of cancer end points. This paper discusses criteria relevant …

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

MJ Thun, SJ Henley, C Patrono - Journal of the National Cancer …, 2002 - academic.oup.com
Numerous experimental, epidemiologic, and clinical studies suggest that nonsteroidal anti-
inflammatory drugs (NSAIDs), particularly the highly selective cyclooxygenase (COX)-2 …

Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

M Oshima, JE Dinchuk, SL Kargman, H Oshima… - Cell, 1996 - cell.com
Two cyclooxygenase isozymes catalyze conversion of arachidonic acid to prostaglandin H
2: constitutive COX-1 and inducible COX-2. To assess the role of COX-2 in colorectal …

COX‐2 is expressed in human pulmonary, colonic, and mammary tumors

RA Soslow, AJ Dannenberg, D Rush, BM Woerner… - cancer, 2000 - Wiley Online Library
BACKGROUND The cyclooxygenase (COX) enzyme catalyzes the formation of
prostaglandins, which can affect cell proliferation and alter the response of the immune …

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

M Murakami, H Naraba, T Tanioka, N Semmyo… - Journal of Biological …, 2000 - ASBMB
Here we report the molecular identification of membrane-bound glutathione (GSH)-
dependent prostaglandin (PG) E 2 synthase (mPGES), a terminal enzyme of the …

Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer

T Kawamori, R Lubet, VE Steele, GJ Kelloff, RB Kaskey… - Cancer research, 1999 - AACR
Curcumin, derived from the rhizome of Curcuma longa L. and having both antioxidant and
anti-inflammatory properties, inhibits chemically induced carcinogenesis in the skin …

[HTML][HTML] Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration

R Langenbach, SG Morham, HF Tiano, CD Loftin… - Cell, 1995 - cell.com
Abstract Cyclooxygenases 1 and 2 (COX-1 and COX-2) are key enzymes in prostaglandin
biosynthesis and the target enzymes for the widely used nonsteroidal anti-inflammatory …